Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 51688-75-6 | MDL No. : | MFCD04114098 |
Formula : | C9H11NO2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | MFTBLGQBZWFKHP-UHFFFAOYSA-N |
M.W : | 165.19 | Pubchem ID : | 2762776 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.22 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 47.58 |
TPSA : | 63.32 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.03 cm/s |
Log Po/w (iLOGP) : | 1.24 |
Log Po/w (XLOGP3) : | 1.8 |
Log Po/w (WLOGP) : | 1.54 |
Log Po/w (MLOGP) : | 0.53 |
Log Po/w (SILICOS-IT) : | 1.29 |
Consensus Log Po/w : | 1.28 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.56 |
Log S (ESOL) : | -2.24 |
Solubility : | 0.959 mg/ml ; 0.00581 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.75 |
Solubility : | 0.295 mg/ml ; 0.00178 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.19 |
Solubility : | 1.05 mg/ml ; 0.00638 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.23 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H317-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
84.5% | Stage #1: for 22 h; Reflux; Inert atmosphere Stage #2: With hydrogenchloride In water |
Preparation of 4-amino-3-ethylbenzoic AcidA suspension of 4-cyano-2-ethylacetanilide (10.1 g, 53.66 mmol) in 20percent aqueous sodium hydroxide (38 mL, 188 mmol) was stirred at reflux, under nitrogen atmosphere for 22 hours. The dark solution was cooled to room temperature, diluted with water (200 mL) and washed with ethyl acetate (2.x.50 mL). The aqueous phase was acidified with concentrated hydrochloric acid to pH 5 and extracted with ethyl acetate (2.x.100 mL). After further acidifying to pH 4 the aqueous phase was further extracted with ethyl acetate (2.x.50 mL) and the combined extracts was washed with brine (50 mL), dried (magnesium sulfate) and evaporated in vacuo. The residual solid was triturated with petroleum ether, removed by filtration, washed with petroleum ether and dried in vacuo. The beige solid (7.49 g, 84.5percent) was 4-amino-3-ethylbenzoic acid of good purity. |
[ 4919-40-8 ]
4-Amino-3,5-dimethylbenzoic acid
Similarity: 0.92
[ 4919-40-8 ]
4-Amino-3,5-dimethylbenzoic acid
Similarity: 0.92
[ 4919-40-8 ]
4-Amino-3,5-dimethylbenzoic acid
Similarity: 0.92